77 related articles for article (PubMed ID: 2175800)
1. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
Ignar DM; Kuhn CM
J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
[TBL] [Abstract][Full Text] [Related]
2. Sleep restriction during opioid abstinence affects the hypothalamic-pituitary-adrenal (HPA) axis in male and female rats.
Raff H; Glaeser BL; Szabo A; Olsen CM; Everson CA
Stress; 2023 Jan; 26(1):2185864. PubMed ID: 36856367
[TBL] [Abstract][Full Text] [Related]
3. The effects of sleep restriction during abstinence on oxycodone seeking: Sex-dependent moderating effects of behavioral and hypothalamic-pituitary-adrenal axis-related phenotypes.
Olsen CM; Glaeser BL; Szabo A; Raff H; Everson CA
Physiol Behav; 2023 Dec; 272():114372. PubMed ID: 37805135
[TBL] [Abstract][Full Text] [Related]
4. Kappa opioid activation changes protein profiles in different regions of the brain relevant to depression.
Varastehmoradi B; Smith KL; Müller HK; Elfving B; Sanchez C; Wegener G
Eur Neuropsychopharmacol; 2023 Jul; 72():9-17. PubMed ID: 37040689
[TBL] [Abstract][Full Text] [Related]
5. Glycogen storage disease presenting as Cushing syndrome.
Stefater MA; Wolfsdorf JI; Ma NS; Majzoub JA
JIMD Rep; 2019 May; 47(1):17-22. PubMed ID: 31240162
[TBL] [Abstract][Full Text] [Related]
6. Effects of Opioid Withdrawal on Psychobiology in People Living with HIV.
Grant I; Krupitsky E; Vetrova M; Umlauf A; Heaton RK; Hauger RL; Toussova O; Franklin DR; Letendre SL; Woody G; Blokhina E; Lioznov D; Zvartau E
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257791
[TBL] [Abstract][Full Text] [Related]
7. Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain.
Ruggiero E; Pambuku A; Caccese M; Lombardi G; Gallio I; Brunello A; Ceccato F; Formaglio F
Front Pain Res (Lausanne); 2023; 4():1256809. PubMed ID: 37810433
[TBL] [Abstract][Full Text] [Related]
8. The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism.
Koekkoek LL; van der Gun LL; Serlie MJ; la Fleur SE
Curr Diab Rep; 2022 Jul; 22(7):301-310. PubMed ID: 35593927
[TBL] [Abstract][Full Text] [Related]
9. Developing Translational Vaccines against Heroin and Fentanyl through Investigation of Adjuvants and Stability.
Blake S; Bremer PT; Zhou B; Petrovsky N; Smith LC; Hwang CS; Janda KD
Mol Pharm; 2021 Jan; 18(1):228-235. PubMed ID: 33301675
[TBL] [Abstract][Full Text] [Related]
10. Early life opioid exposure and potential long-term effects.
Harder HJ; Murphy AZ
Neurobiol Stress; 2019 Feb; 10():100156. PubMed ID: 31338390
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release.
Skupio U; Tertil M; Bilecki W; Barut J; Korostynski M; Golda S; Kudla L; Wiktorowska L; Sowa JE; Siwiec M; Bobula B; Pels K; Tokarski K; Hess G; Ruszczycki B; Wilczynski G; Przewlocki R
Neuropsychopharmacology; 2020 Jan; 45(2):404-415. PubMed ID: 31254970
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Perinatal Oxycodone Exposure on Behavioral Outcome in a Rodent Model.
Sithisarn T; Legan SJ; Westgate PM; Wilson M; Wellmann K; Bada HS; Barron S
Front Pediatr; 2017; 5():180. PubMed ID: 28971091
[TBL] [Abstract][Full Text] [Related]
13. Role of κ-Opioid Receptors in the Bed Nucleus of Stria Terminalis in Reinstatement of Alcohol Seeking.
Lê AD; Funk D; Coen K; Tamadon S; Shaham Y
Neuropsychopharmacology; 2018 Mar; 43(4):838-850. PubMed ID: 28589966
[TBL] [Abstract][Full Text] [Related]
14. Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.
Butelman ER; Kreek MJ
Curr Top Behav Neurosci; 2018; 39():175-192. PubMed ID: 27225498
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated morphine withdrawal on spatial learning, memory and serum cortisol level in mice.
Matinfar M; Esfahani MM; Aslany N; Davoodi SH; Parsaei P; Zarei G; Reisi P
Adv Biomed Res; 2013; 2():80. PubMed ID: 24524030
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.
Zhou Y; Leri F; Ho A; Kreek MJ
Neurochem Res; 2013 Sep; 38(9):1850-60. PubMed ID: 23771528
[TBL] [Abstract][Full Text] [Related]
17. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
Kreek MJ; Levran O; Reed B; Schlussman SD; Zhou Y; Butelman ER
J Clin Invest; 2012 Oct; 122(10):3387-93. PubMed ID: 23023708
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.
Zhou Y; Proudnikov D; Yuferov V; Kreek MJ
Brain Res; 2010 Feb; 1314():235-52. PubMed ID: 19914222
[TBL] [Abstract][Full Text] [Related]
19. Repeated amphetamine administration in rats revealed consistency across days and a complete dissociation between locomotor and hypothalamic-pituitary-adrenal axis effects of the drug.
Gagliano H; Andero R; Armario A; Nadal R
Psychopharmacology (Berl); 2009 Dec; 207(3):447-59. PubMed ID: 19809808
[TBL] [Abstract][Full Text] [Related]
20. Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice.
Ide S; Sora I; Ikeda K; Minami M; Uhl GR; Ishihara K
Neuropharmacology; 2010 Jan; 58(1):241-7. PubMed ID: 19596019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
